1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Chronic Myelogenous Leukemia - Chronic Phase: new trials by email Literature Review of Chronic Myelogenous Leukemia - Chronic Phase trials Research Report on Chronic Myelogenous Leukemia - Chronic Phase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Dasatinib Tablets - Chronic Myelogenous Leukemia - Chronic Phase | Phase 4 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 62 | 2016-05-10 | 2021-06-14 |
Leukemia, Myeloid, Chronic-Phase (1)
Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Dasatinib (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)
China (1)